Genfit SA Sustainability Reports

Genfit S.A. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutic and diagnostic solutions for rare, life-threatening liver diseases. The company specializes in research regarding acute-on-chronic liver failure, therapeutic assets with complementary mechanisms of action, and diagnostic biomarker platforms.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 969500XPWN2DMZQA5X73

FIGI: BBG001SS5QC9

7 reports from 2020 to 2025

• Genfit SA 2025 Universal Registration Document
• Genfit SA 2025 Extra-Financial Performance Report
• Genfit SA 2025 Non-Financial Performance Report
• Genfit SA 2024 Extra-Financial Performance Report
• Genfit SA 2023 Extra-Financial Performance Report